ELF Stock Analysis: ELF Beauty | NYSE
Household & Personal Products | NYSE, USA | Market Cap: 3.925m USD | 12M Return: -37.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 222M
EPS Trend: 26.2%
Qual. Beats: 0
Rev. Trend: 96.0%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 9.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: under 40 is mostly noise, over 50 gets interesting, and over 70 is strong.
e.l.f. Beauty, Inc. is a U.S.-based mass-market beauty company that designs, markets, and distributes cosmetics and skin care products globally. Its portfolio spans eye, lip, face, and skin care items sold under the e.l.f. Cosmetics, e.l.f. Skin, Well People, Naturium, and Rhode brands, reaching customers through both national and international retailers and its own e-commerce platforms.
The company was founded in 2004 and is headquartered in Oakland, California, originally operating as J.A. Cosmetics Holdings, Inc. before adopting its current name in April 2016. It trades on the NYSE under the ticker ELF and is classified within the Personal Care Products sub-industry of the broader Consumer Staples sector, reflecting its positioning in everyday, repeat-purchase personal care goods.
Its business model combines a multi-brand portfolio strategy with a hybrid distribution approach, balancing mass-market retail shelf presence with direct-to-consumer digital sales-an approach common among modern personal care companies seeking both scale and consumer data capture.
- Rhode acquisition accelerates premium skincare revenue growth
- China tariff exposure pressures product gross margins
- Affordable pricing captures market share from prestige beauty brands
| Net Income: 26.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.30 > 1.0 |
| NWC/Revenue: 27.69% < 20% (prev 27.67%; Δ 0.02% < -1%) |
| CFO/TA 0.09 > 3% & CFO 212.5m > Net Income 26.3m |
| Net Debt (704.8m) to EBITDA (160.6m): 4.39 < 3 |
| Current Ratio: 2.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (59.9m) vs 12m ago 2.74% < -2% |
| Gross Margin: 70.72% > 18% (prev 71.24%; Δ -0.51% > 0.5%) |
| Asset Turnover: 89.86% > 50% (prev 105.2%; Δ -15.38% > 0%) |
| Interest Coverage Ratio: 1.99 > 6 (EBIT TTM 81.2m / Interest Expense TTM 40.8m) |
| A: 0.19 (Total Current Assets 789.4m - Total Current Liabilities 336.2m) / Total Assets 2.39b |
| B: -0.07 (Retained Earnings -155.9m / Total Assets 2.39b) |
| C: 0.04 (EBIT TTM 81.2m / Avg Total Assets 1.82b) |
| D: 0.89 (Book Value of Equity 1.13b / Total Liabilities 1.26b) |
| Altman-Z'' = 2.27 = BBB |
| DSRI: 1.11 (Receivables 174.6m/126.0m, Revenue 1.64b/1.31b) |
| GMI: 1.01 (GM 71.24% / 70.72%) |
| AQI: 1.20 (AQ_t 0.65 / AQ_t-1 0.54) |
| SGI: 1.25 (Revenue 1.64b / 1.31b) |
| TATA: -0.08 (NI 26.3m - CFO 212.5m) / TA 2.39b) |
| Beneish M = -2.64 (Cap -4..+1) = A |
As of July 02, 2026, the stock is trading at USD 74.00 with a total of 4,020,651 shares traded. Over the past week, the price has changed by +22.02%, over one month by +47.22%, over three months by +26.40% and over the past year by -37.83%.
Current recommended Stop Loss: 65.90 (which is 10.9% or 2.2 ATR below the current price).
ELF Beauty has received a consensus analysts rating of 4.24. Therefore, it is recommended to buy ELF.
- StrongBuy: 9
- Buy: 3
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 71.9 | -2.9% |
P/E Trailing = 150.0909
P/E Forward = 19.2308
P/S = 14.6273
P/B = 3.3382
P/EG = 1.3707
Revenue TTM = 1.64b USD
EBIT TTM = 81.2m USD
EBITDA TTM = 160.6m USD
Long Term Debt = 809.3m USD (from longTermDebt, last quarter)
Short Term Debt = 37.6m USD (from shortTermDebt, last quarter)
Debt = 994.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 77.6m
Net Debt = 704.8m USD (calculated: Debt 994.5m - CCE 289.7m)
Enterprise Value = 4.63b USD (3.93b + Debt 994.5m - CCE 289.7m)
Interest Coverage Ratio = 1.99 (Ebit TTM 81.2m / Interest Expense TTM 40.8m)
EV/FCF = 24.36x (Enterprise Value 4.63b / FCF TTM 190.1m)
FCF Yield = 4.10% (FCF TTM 190.1m / Enterprise Value 4.63b)
FCF Margin = 11.61% (FCF TTM 190.1m / Revenue TTM 1.64b)
Net Margin = 1.61% (Net Income TTM 26.3m / Revenue TTM 1.64b)
Gross Margin = 70.72% ((Revenue TTM 1.64b - Cost of Revenue TTM 479.1m) / Revenue TTM)
Gross Margin QoQ = 72.66% (prev 70.99%)
Tobins Q-Ratio = 1.93 (Enterprise Value 4.63b / Total Assets 2.39b)
Interest Expense / Debt = 4.10% (Interest Expense 40.8m / Debt 994.5m)
Taxrate = 34.95% (14.1m / 40.5m)
NOPAT = 52.8m (EBIT 81.2m * (1 - 34.95%))
Current Ratio = 2.35 (Total Current Assets 789.4m / Total Current Liabilities 336.2m)
Debt / Equity = 0.88 (Debt 994.5m / totalStockholderEquity, last quarter 1.13b)
Debt / EBITDA = 4.39 (Net Debt 704.8m / EBITDA 160.6m)
Debt / FCF = 3.71 (Net Debt 704.8m / FCF TTM 190.1m)
Total Stockholder Equity = 1.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.45% (Net Income 26.3m / Total Assets 2.39b)
RoE = 2.49% (Net Income TTM 26.3m / Total Stockholder Equity 1.06b)
RoCE = 4.35% (EBIT 81.2m / Capital Employed (Equity 1.06b + L.T.Debt 809.3m))
RoIC = 2.62% (NOPAT 52.8m / Invested Capital 2.01b)
WACC = 8.73% (E(3.93b)/V(4.92b) * Re(10.27%) + D(994.5m)/V(4.92b) * Rd(4.10%) * (1-Tc(0.35)))
Discount Rate = 10.27% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 28.89 | Cagr: 1.45%
[DCF] Terminal Value 76.74% ; FCFF base≈160.2m ; Y1≈183.6m ; Y5≈270.2m
[DCF] Fair Price = 52.24 (EV 3.81b - Net Debt 704.8m = Equity 3.10b / Shares 59.4m; r=8.73% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 26.17 | EPS CAGR: 3.01% | SUE: 0.15 | # QB: 0
Revenue Correlation: 96.02 | Revenue CAGR: 33.98% | SUE: 1.44 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.68 | Chg30d=-3.32% | Revisions=-29% | Analysts=18
EPS current Year (2027-03-31): EPS=3.30 | Chg30d=-8.48% | Revisions=-81% | GrowthEPS=+5.4% | GrowthRev=+13.7%
EPS next Year (2028-03-31): EPS=3.65 | Chg30d=-8.68% | Revisions=-69% | GrowthEPS=+10.7% | GrowthRev=+7.4%
[Analyst] Revisions Ratio: -81%